Results 11 to 20 of about 316,189 (194)

Tropomyosin receptor kinase B-mediated signaling in integration of neuropathic pain and obesity in diabetic polyneuropathy

open access: yesEinstein (São Paulo), 2021
Objective: To assess the quantitative serum levels of tropomyosin receptor kinase receptor B, and to estimate its association with serum concentration of brain-derived neurotrophic factor and obesity in patients with painful and painless forms of ...
Tamara Filimonova, Yulia Karakulova
doaj   +2 more sources

Contemporary management of pain in cirrhosis: Toward precision therapy for pain

open access: yesHepatology, EarlyView., 2022
Abstract Chronic pain is highly prevalent in patients with cirrhosis and is associated with poor health‐related quality of life and poor functional status. However, there is limited guidance on appropriate pain management in this population, and pharmacologic treatment can be harmful, leading to adverse outcomes, such as gastrointestinal bleeding ...
Alexis Holman   +4 more
wiley   +1 more source

Alterations of retinal thickness measured by optical coherence tomography correlate with neurophysiological measures in diabetic polyneuropathy

open access: yesJournal of Diabetes Investigation, 2021
Aims/Introduction Diabetic polyneuropathy (DPN) and diabetic retinopathy (DR) are traditionally regarded as microvascular complications. However, these complications may share similar neurodegenerative pathologies.
Yuichiro Yamada   +24 more
doaj   +1 more source

CLINICAL FEATURES OF PATIENTS WITH DIABETIC POLYNEUROPATHY [PDF]

open access: yes, 2017
The authors have studied the clinical features and state of surface and deep types of sensitivity in patients with diabetic polyneuropathy. In patients having diabetic polyneuropathy peripheral nerves of the lower limbs get affected more compared to the ...
I. I. Bilous   +9 more
core   +2 more sources

α-Lipoic acid as the main pharmacological drug for in- and outpatient treatment of diabetic polyneuropathy

open access: yesМедицинский совет, 2016
α-Lipoic acid (thioctic) (ALA) is the most applicable pharmacological drug for treatment of diabetic polyneuropathy. The articles explores the results of experimental studies on α-Lipoic acid effect upon formation mechanisms of peripheral nerves ...
I. A. Strokov, A. S. Phokina
doaj   +1 more source

Correlates of diabetic polyneuropathy of the elderly in Sub-Saharan Africa.

open access: yesPLoS ONE, 2020
BackgroundDiabetic polyneuropathy is associated with significant physical disability among older adults. However, their frequency and correlates are not well known in the older adults in Sub-Saharan-Africa.
Nadine Simo   +8 more
doaj   +1 more source

Follow-up study of sensory-motor polyneuropathy in Type 1 (insulin-dependent) diabetic subjects after simultaneous pancreas and kidney transplantation and after graft rejection [PDF]

open access: yes, 1991
The influence of successful simultaneous pancreas and kidney transplantation on peripheral polyneuropathy was investigated in 53 patients for a mean observation period of 40.3 months. Seventeen patients were followed-up for more than 3 years.
Illner, Wolf-Dieter   +8 more
core   +1 more source

Differential diagnosis of polyneuropathies in diabetes mellitus

open access: yesМедицинский совет, 2021
Diabetic polyneuropathy (DPN) is heterogeneous in its clinical course and clinical manifestations. Depending on the primary lesion of large or small nerve fibers, different onset, course and clinical manifestations of polyneuropathy are possible.
V. N. Khramilin
doaj   +1 more source

Clinical periodontal diagnosis

open access: yesPeriodontology 2000, EarlyView., 2023
Abstract Periodontal diseases include pathological conditions elicited by the presence of bacterial biofilms leading to a host response. In the diagnostic process, clinical signs such as bleeding on probing, development of periodontal pockets and gingival recessions, furcation involvement and presence of radiographic bone loss should be assessed prior ...
Giovanni E. Salvi   +5 more
wiley   +1 more source

Treating painful diabetic polyneuropathy [PDF]

open access: yesBMJ, 2007
The incidence of diabetes is expected to double over the next two decades, which will result in more people with complications of diabetes.1 Diabetic polyneuropathy is one of the most common, with a prevalence of around 30-50%. It can have a major impact on patients' quality of life, and treatment is usually needed for many years.2 3 Community based
Edward B, Jude, Nicolaas, Schaper
openaire   +2 more sources

Home - About - Disclaimer - Privacy